TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
JBIO

Jade Biosciences, Inc.

Healthcare · Biotechnology

14.70$ +0.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement JBIO
Line item 2020 2021 2022 2023 2024 2025
– – – – – 0.00
0.00 0.02 0.10 0.13 0.35 0.00
0.00 -0.02 -0.10 -0.13 -0.35 0.00
11.38 21.49 55.24 85.36 65.13 2.97
– – – – 0.01 0.64
12.74 32.99 76.04 108.08 91.00 3.62
-12.75 -33.01 -76.14 -108.21 -91.35 -3.62
0.11 – – – – –
-13.78 -32.92 -73.64 -100.31 -85.19 -4.06
– 0.00 0.04 0.07 0.07 0.00
-13.78 -32.92 -73.67 -100.38 -85.26 -4.06
-13.67 -32.90 -73.54 -100.18 -84.85 -4.06

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?